OptimizeRx (OPRX) Current Deferred Revenue (2010 - 2026)
OptimizeRx recorded quarterly Current Deferred Revenue of $669000.0 in Q1 2026, up 33.0% quarter-over-quarter from $503000.0 in Q4 2025, and up 30.92% year-over-year from $511000.0 in Q1 2025.
OptimizeRx's Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $669000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 30.92% year-over-year to $669000.0; the TTM figure through Mar 2026 stood at $669000.0 (up 30.92% YoY), while the FY2025 annual figure was $503000.0, up 6.34% from the prior year.
- Current Deferred Revenue came in at $669000.0 for Q1 2026 at OptimizeRx, up from $503000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1.3 million in Q1 2022 to a low of $164000.0 in Q4 2022.
- A 5-year average of $617422.2 and a median of $511000.0 in 2025 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue sank 88.2% in 2022 and soared 318.09% in 2024, its largest moves.
- OptimizeRx's Current Deferred Revenue stood at $164000.0 in 2022, then gained by 4.88% to $172000.0 in 2023, then surged by 175.0% to $473000.0 in 2024, then advanced by 6.34% to $503000.0 in 2025, then jumped by 33.0% to $669000.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $669000.0, $503000.0, and $395000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 669,000.00 |
| Dec 31, 2025 | 503,000.00 |
| Sep 30, 2025 | 395,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | 511,000.00 |
| Dec 31, 2024 | 473,000.00 |
| Sep 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 904,000.00 |
| Dec 31, 2023 | 172,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 451,000.00 |
| Mar 31, 2023 | 735,000.00 |
| Dec 31, 2022 | 164,000.00 |
| Sep 30, 2022 | 673,214.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 348,405.00 |
| Jun 30, 2021 | 319,609.00 |
| Mar 31, 2021 | 448,140.00 |
| Dec 31, 2020 | 285,795.00 |
| Sep 30, 2020 | 461,277.00 |
| Jun 30, 2020 | 648,692.00 |
| Mar 31, 2020 | 491,438.00 |
| Dec 31, 2019 | 580,014.00 |
| Sep 30, 2019 | 1.12 Mn |
| Jun 30, 2019 | 769,391.00 |
| Mar 31, 2019 | 645,824.00 |
| Dec 31, 2018 | 610,625.00 |
| Sep 30, 2018 | 813,316.00 |
| Jun 30, 2018 | 845,153.00 |
| Mar 31, 2018 | 856,914.00 |
| Dec 31, 2017 | 507,160.00 |
| Sep 30, 2017 | 729,092.00 |
| Jun 30, 2017 | 1.04 Mn |
| Mar 31, 2017 | 1.33 Mn |
| Dec 31, 2016 | 386,581.00 |
| Sep 30, 2016 | 766,107.00 |
| Jun 30, 2016 | 667,249.00 |
| Mar 31, 2016 | 845,226.00 |
| Dec 31, 2015 | 227,002.00 |
| Sep 30, 2015 | 293,112.00 |
| Jun 30, 2015 | 336,213.00 |
| Mar 31, 2015 | 253,438.00 |
| Dec 31, 2014 | 120,130.00 |
| Sep 30, 2014 | 118,949.00 |
| Jun 30, 2014 | 301,178.00 |
| Mar 31, 2014 | 437,521.00 |
| Dec 31, 2013 | 226,272.00 |
| Sep 30, 2013 | 161,132.00 |
| Jun 30, 2013 | 42,620.00 |
| Mar 31, 2013 | 80,772.00 |
| Dec 31, 2012 | 49,252.00 |
| Sep 30, 2012 | 311,774.00 |
| Mar 31, 2012 | 203,153.00 |
| Dec 31, 2011 | 330,605.00 |
| Sep 30, 2011 | 140,300.00 |
| Jun 30, 2011 | 152,610.00 |
| Dec 31, 2010 | 225,720.00 |